A Hallberg

Characterization of a Set of HIV-1 Protease Inhibitors Using Binding Kinetics Data from a Biosensor-Based Screen

L. Vrang, B. Samuelsson, A. Hallberg, 2000, Journal of biomolecular screening.

P1/P1' modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays.

J. Hulten, B. Samuelsson, A. Hallberg, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities.

J. Åqvist, J. Hulten, B. Samuelsson, 1997, Journal of medicinal chemistry.

Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii.

S F Queener, J Aqvist, A Hallberg, 2001, Journal of medicinal chemistry.

Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

H Lennernäs, A. Hallberg, S. Winiwarter, 1998, Journal of medicinal chemistry.

Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors.

J. Hulten, B. Samuelsson, A. Hallberg, 2001, Journal of medicinal chemistry.

Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs

J. Hulten, L. Vrang, A. Hallberg, 1997, Antimicrobial agents and chemotherapy.

Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor.

K Osterlund, J. Hulten, A. Hallberg, 1997, Journal of medicinal chemistry.

Resistance Profiles of Cyclic and Linear Inhibitors of HIV-1 Protease

J. Hulten, B. Samuelsson, A. Hallberg, 2002, Antiviral chemistry & chemotherapy.